Search
NLS Pharmaceutics AG
NLSPAdd to Watchlist
0.762USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
20.58MMarket Cap
--P/E TTM
NLS Pharmaceutics AG Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-2.16
91.79%
Analyst Rating
2025-05-19
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2025 earnings report, its current assets were 3.18M, with a year-on-year change of 42.98.
What are the total assets of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2025 earnings report, its total assets of NLS Pharmaceutics AG were 11.45M, with a year-on-year change of 412.51.
What are the total liabilities of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2025 earnings report, its total liabilities of NLS Pharmaceutics AG were 4.20M, with a year-on-year change of 407.40.
What is the total equity of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2025 earnings report, its total equity of NLS Pharmaceutics AG was 7.25M, with a year-on-year change of 415.51.
What is the net investment of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2025 earnings report, its net investment of NLS Pharmaceutics AG was 1.70M, with a year-on-year change of 43500.56.
What is the net financing of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2025 earnings report, its net financing of NLS Pharmaceutics AG was 2.63M, with a year-on-year change of -47.83.
What is the Earnings Per Share (EPS) of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2025 earnings report, its Earnings Per Share (EPS) was -2.16, with a year-on-year change of 91.79.
What is the Return on Assets (ROA) of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2025 earnings report, its Return on Assets (ROA) was -121.36, with a year-on-year change of -24.98.
What is the operating profit of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2025 earnings report, its operating profit was -2.47M, with a year-on-year change of 31.96.